Compounding pharmacies rise in popularity but bring questions about safety

Minnesota Department of Health/AP - This photo provided by the Minnesota Department of Health shows shows vials of the injectable steroid product made by New England Compounding Center implicated in a fungal meningitis outbreak.

Pharmacy compounding, the mixing of drugs for individual patients, was once a quaint activity depicted on drug-store calendars from the 1950s. It has roared back in the 21st century, driven by the rise of out-of-hospital surgical care, the high prices and shortages of drugs, and the real or imagined benefit of “personalized medicine.”

Today, nearly every place medical care occurs — hospitals, doctor’s offices, home-health companies — now gets at least some of its drugs in forms that aren’t available off the shelf from pharmaceutical houses.

Related stories

A decade of problems with NECC

A decade of problems with NECC

A Hill report describes contamination of medicines and mass production of supposedly custom-made drugs.

Deadly meningitis outbreak ‘just the tip of an industry iceberg,’ report says

Deadly meningitis outbreak ‘just the tip of an industry iceberg,’ report says

State boards failed to regulate safety at specialty pharmacies, congressional report finds.

The practice burst into the national spotlight this month when cases of a rare brain infection, widely scattered across the country, were linked to a drug mixed by a compounding pharmacy in Massachusetts. As of Saturday, 198 illnesses and 15 deaths had been reported from 13 states.

Hospital pharmacists no longer compound drugs just for premature infants or patients with unusual conditions. Corner druggists see compounding as a more lucrative and interesting job than bagging blister-pack prescriptions. Chain drug stores are getting into the business. And entrepreneurs are taking up mortar and pestle to meet the demand, one of them being the New England Compounding Center, which is at the middle of the current outbreak.

That company in Framingham, Mass., shipped nearly 18,000 vials of methylprednisolone acetate, a steroid injected around the spinal cord to relieve pain, to buyers in 23 states. How many of the vials were contaminated is unknown. About 14,000 people have been injected with material from the three tainted lots. Health officials expect more cases of fungal meningitis to appear.

Whether that volume of sales tipped the company out of the category of “compounding pharmacy” and into that of “drug manufacturer” is a matter of dispute. So is the issue of who has principal responsibility — Massachusetts’s pharmacy board or the federal government’s Food and Drug Administration — to oversee such operations and prevent disasters like the one that’s happening.

What’s not in dispute is how much U.S. medicine has come to rely on this little-known and little-regulated part of the economy.

Compounded drug benefits

“It’s like buying your electricity from a different supplier. It looks like you’re getting the same stuff, but evidently you’re not,” says a physician at one of the seven outpatient treatment centers in Maryland that received methylprednisolone from a contaminated lot from the New England Compounding Center. A pain specialist, he’s been using compounding pharmacies “for at least five years, closer to 10.” He spoke on the condition of anonymity on the advice of his lawyer.

Compounders are especially important for patients with multiple sclerosis who get a mixture of drugs that are not commercially available and are continuously infused into the spinal canal. The clinic also turns to compounders for preservative-free injectable steroids because some of the doctors there think that alcohol preservatives in conventional preparations can be irritating.

Loading...

Comments

Add your comment
 
Read what others are saying About Badges